Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CLPT NASDAQ:EDAP NASDAQ:NPCE NASDAQ:SMTI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLPTClearPoint Neuro$11.08+8.1%$11.05$9.76▼$19.22$291.38M0.89319,037 shs410,453 shsEDAPEDAP TMS$2.52-8.4%$1.57$1.21▼$3.33$102.83M-0.21163,681 shs254,549 shsNPCENeuroPace$9.61+2.7%$9.28$5.45▼$18.98$309.64M1.9200,756 shs226,921 shsSMTISanara MedTech$34.04+1.6%$28.96$23.53▼$39.08$298.32M1.1939,612 shs12,772 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLPTClearPoint Neuro+8.10%+5.62%+5.22%-20.46%-11.08%EDAPEDAP TMS-8.36%+38.46%+98.43%+41.57%-21.37%NPCENeuroPace+2.67%+5.49%+10.46%-26.92%+35.35%SMTISanara MedTech+1.58%+0.92%+38.83%+15.43%-1.59%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLPTClearPoint Neuro$11.08+8.1%$11.05$9.76▼$19.22$291.38M0.89319,037 shs410,453 shsEDAPEDAP TMS$2.52-8.4%$1.57$1.21▼$3.33$102.83M-0.21163,681 shs254,549 shsNPCENeuroPace$9.61+2.7%$9.28$5.45▼$18.98$309.64M1.9200,756 shs226,921 shsSMTISanara MedTech$34.04+1.6%$28.96$23.53▼$39.08$298.32M1.1939,612 shs12,772 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLPTClearPoint Neuro+8.10%+5.62%+5.22%-20.46%-11.08%EDAPEDAP TMS-8.36%+38.46%+98.43%+41.57%-21.37%NPCENeuroPace+2.67%+5.49%+10.46%-26.92%+35.35%SMTISanara MedTech+1.58%+0.92%+38.83%+15.43%-1.59%Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLPTClearPoint Neuro$31.39M10.04N/AN/A$0.92 per share12.04EDAPEDAP TMS$69.18M1.36N/AN/A$1.18 per share2.14NPCENeuroPace$79.91M3.98N/AN/A$0.27 per share35.59SMTISanara MedTech$86.67M3.50N/AN/A$4.45 per share7.65Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLPTClearPoint Neuro-$18.91M-$0.81N/AN/AN/A-66.15%-94.44%-51.58%11/6/2025 (Estimated)EDAPEDAP TMS-$20.58M-$0.61N/AN/AN/A-33.49%-56.85%-26.83%11/5/2025 (Estimated)NPCENeuroPace-$27.14M-$0.84N/AN/AN/A-29.29%-168.61%-25.48%11/11/2025 (Estimated)SMTISanara MedTech-$9.66M-$1.16N/AN/AN/A-10.22%-26.43%-10.69%11/11/2025 (Estimated)Latest EDAP, NPCE, SMTI, and CLPT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025SMTISanara MedTech-$0.33-$0.23+$0.10-$0.23$25.15 million$25.83 million8/12/2025Q2 2025CLPTClearPoint Neuro-$0.20-$0.21-$0.01-$0.21$9.20 million$9.22 million8/12/2025Q2 2025NPCENeuroPace-$0.24-$0.26-$0.02-$0.26$23.08 million$23.52 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLPTClearPoint NeuroN/AN/AN/AN/AN/AEDAPEdap TmsN/AN/AN/AN/AN/ANPCENeuroPaceN/AN/AN/AN/AN/ASMTISanara MedTechN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLPTClearPoint Neuro1.467.306.45EDAPEDAP TMS0.041.511.05NPCENeuroPace3.025.474.51SMTISanara MedTech1.252.262.03Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLPTClearPoint Neuro30.08%EDAPEDAP TMS62.74%NPCENeuroPace78.83%SMTISanara MedTech8.10%Insider OwnershipCompanyInsider OwnershipCLPTClearPoint Neuro6.97%EDAPEDAP TMS0.23%NPCENeuroPace20.50%SMTISanara MedTech42.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLPTClearPoint Neuro11028.43 million26.45 millionOptionableEDAPEDAP TMS23037.39 million37.31 millionOptionableNPCENeuroPace17033.08 million26.30 millionOptionableSMTISanara MedTech608.90 million5.11 millionNot OptionableEDAP, NPCE, SMTI, and CLPT HeadlinesRecent News About These CompaniesSanara MedTech: Growth Remains Strong As Debt Concerns RecedeSeptember 4 at 3:04 PM | seekingalpha.comSanara MedTech stock falls after CEO succession announcementSeptember 3 at 7:23 PM | za.investing.comSanara MedTech Shares Dip Following CEO Succession AnnouncementSeptember 3 at 7:23 PM | msn.comSeth Yon Named CEO of Sanara MedTech Inc., Ron Nixon to Remain Executive ChairmanSeptember 2 at 4:51 PM | quiverquant.comQSanara MedTech Inc. Announces Chief Executive Officer TransitionSeptember 2 at 4:30 PM | globenewswire.comAnalysts Expect Breakeven For Sanara MedTech Inc. (NASDAQ:SMTI) Before LongSeptember 1, 2025 | finance.yahoo.comSanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025August 27, 2025 | globenewswire.comSanara Medtech Inc News (SMTI) - Investing.comAugust 23, 2025 | investing.comQ3 EPS Estimates for Sanara MedTech Boosted by HC WainwrightAugust 22, 2025 | marketbeat.comHC Wainwright Forecasts Sanara MedTech Q1 EarningsAugust 21, 2025 | marketbeat.comFY2025 EPS Estimate for Sanara MedTech Raised by AnalystAugust 19, 2025 | marketbeat.comSanara MedTech price target raised to $54 from $53 at H.C. WainwrightAugust 18, 2025 | msn.comSanara MedTech (NASDAQ:SMTI) Posts Quarterly Earnings Results, Beats Expectations By $0.10 EPSAugust 16, 2025 | marketbeat.comSanara MedTech Reports Strong Revenue Growth in Q2 2025August 14, 2025 | msn.comSanara MedTech Inc. (NASDAQ:SMTI) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | msn.comSanara MedTech Inc. (SMTI) Q2 2025 Earnings Call TranscriptAugust 13, 2025 | seekingalpha.comSanara MedTech Sales Jump 28 PercentAugust 13, 2025 | theglobeandmail.comSanara MedTech Inc. (SMTI) Reports Q2 Loss, Tops Revenue EstimatesAugust 13, 2025 | zacks.comSanara MedTech Inc. Reports Second Quarter 2025 Financial Results (Unaudited)August 13, 2025 | globenewswire.comSanara MedTech Inc (SMTI) Q2 2025: Everything You Need To Know Ahead Of EarningsAugust 12, 2025 | finance.yahoo.comSanara MedTech (NASDAQ:SMTI) investors are sitting on a loss of 12% if they invested three years agoAugust 10, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeEDAP, NPCE, SMTI, and CLPT Company DescriptionsClearPoint Neuro NASDAQ:CLPT$11.08 +0.83 (+8.10%) Closing price 09/4/2025 04:00 PM EasternExtended Trading$11.44 +0.36 (+3.25%) As of 09/4/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.EDAP TMS NASDAQ:EDAP$2.52 -0.23 (-8.36%) Closing price 09/4/2025 04:00 PM EasternExtended Trading$2.48 -0.04 (-1.59%) As of 09/4/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.NeuroPace NASDAQ:NPCE$9.61 +0.25 (+2.67%) Closing price 09/4/2025 04:00 PM EasternExtended Trading$9.62 +0.01 (+0.05%) As of 09/4/2025 06:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.Sanara MedTech NASDAQ:SMTI$34.04 +0.53 (+1.58%) Closing price 09/4/2025 04:00 PM EasternExtended Trading$34.09 +0.05 (+0.15%) As of 09/4/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Insider Selling: Risk Signal or Normal Activity? Buy the Dip? GitLab’s Bullish Case Outweighs the Bears Affirm Crushes Earnings Expectations, Turns Bears into Believers Gold’s Explosive Rally: GDX ETF May Be the Fast Track to Profits Dollar Tree Plunges Into Buy-Zone: A Robust Rebound Is Expected Zscaler Shares Can Hit a Fresh High Before Year-End Why Qualcomm Is Outperforming NVIDIA After Months of Lagging Alphabet Stock Surges After Dodging Harsh Antitrust Remedies Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
